PLSE
Pulse Biosciences, Inc.NASDAQHealthcare$23.00-0.13%ClosedMarket Cap: $1.56B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
19.22
P/S
4467.85
EV/EBITDA
-20.43
DCF Value
$1.06
FCF Yield
-3.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
-204.3%
Operating Margin
-21982.6%
Net Margin
-20794.6%
ROE
-73.5%
ROA
-78.5%
ROIC
-85.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $264.0K | -96.6% | $-18.3M | $-17.4M | $-0.26 | — |
| FY 2025 | $350.0K | -360.0% | $-76.9M | $-72.8M | $-1.08 | — |
| Q3 2025 | $86.0K | -224.4% | $-20.4M | $-19.4M | $-0.29 | — |
| Q2 2025 | $0.00 | -Infinity% | $-20.3M | $-19.2M | $-0.28 | — |
| Q1 2025 | $0.00 | NaN% | $-18.0M | $-16.8M | $-0.25 | — |
| Q4 2024 | $0.00 | NaN% | $-20.3M | $-19.4M | $-0.33 | — |
| FY 2024 | $0.00 | NaN% | $-56.3M | $-53.6M | $-0.92 | — |
| Q3 2024 | $0.00 | NaN% | $-13.7M | $-12.7M | $-0.21 | — |
| Q2 2024 | $0.00 | NaN% | $-11.7M | $-11.4M | $-0.20 | — |
| Q1 2024 | $0.00 | -Infinity% | $-10.6M | $-10.1M | $-0.18 | — |
| Q4 2023 | $0.00 | NaN% | $-12.5M | $-11.9M | $-0.22 | — |
| FY 2023 | $0.00 | -Infinity% | $-43.6M | $-42.2M | $-0.88 | — |